Serotonin 5-hydroxytryptamine 3A receptor (5-HT3A receptor)

The serotonin 5-hydroxytryptamine 3A receptor (5-HT3A receptor) is a ligand-gated ion channel belonging to the Cys-loop receptor family, distinct from other serotonin receptors that are G protein-coupled[1][4][8]. Functional 5-HT3 receptors are assembled as pentamers, either as homo-oligomers of 5-HT3A subunits or hetero-oligomers with other subunits (5-HT3B-E)[1][5][8]. This receptor mediates fast excitatory neurotransmission in the central and peripheral nervous system by allowing sodium, potassium, and calcium ions to cross the plasma membrane upon serotonin binding[1][8]. It plays a central role in the regulation of nausea, gut motility, and various neuropsychological processes including anxiety and addiction, making it a validated therapeutic target for antiemetics and under investigation for psychiatric applications[3][4][6][9]. Multiple clinically approved antagonists, especially the "setron" class (ondansetron, granisetron, palonosetron, etc.), act by competitively blocking serotonin from activating the receptor, thereby preventing downstream signaling related to emesis and other physiological responses[2][6]. Variability in receptor genetics and expression can impact individual responses to these drugs and disease phenotypes, offering potential utility as a biomarker[9]. Safety is generally good but not without concern, especially with certain agents or patient populations (QT prolongation, ischemic colitis, CNS side effects)[6][9].

Other names

5-HT3A5-HT3A receptor5-HT3 receptor (specifically refers to the A subunit homopentamer)HTR3A

Competitive antagonism (setron class, e.g., ondansetron) Competitive agonism (e.g., 2-methyl-5-HT) Allosteric modulation (predicted for some agents and ligands)